Bioequivalence Study of Paroxetine Immediate Release (IR) Tablets Manufactured in GlaxoSmithKline Tianjin (GSKT) and Mississauga Sites in Healthy Chinese Subjects

NCT03329573 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Anxiety Disorders

Interventions

DRUG: Paroxetine IR tablets A
DRUG: Paroxetine IR tablets B

Sponsor

GlaxoSmithKline